NM_001012339.3:c.32G>T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001012339.3(DNAJC21):c.32G>T(p.Arg11Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000101 in 1,577,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R11P) has been classified as Uncertain significance.
Frequency
Consequence
NM_001012339.3 missense
Scores
Clinical Significance
Conservation
Publications
- bone marrow failure syndrome 3Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- Shwachman-Diamond syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJC21 | NM_001012339.3 | c.32G>T | p.Arg11Leu | missense_variant | Exon 1 of 12 | ENST00000648817.1 | NP_001012339.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151306Hom.: 0 Cov.: 29 show subpopulations
GnomAD2 exomes AF: 0.0000186 AC: 4AN: 215552 AF XY: 0.0000253 show subpopulations
GnomAD4 exome AF: 0.00000982 AC: 14AN: 1425856Hom.: 0 Cov.: 31 AF XY: 0.0000141 AC XY: 10AN XY: 709372 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151306Hom.: 0 Cov.: 29 AF XY: 0.0000135 AC XY: 1AN XY: 73862 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.32G>T (p.R11L) alteration is located in exon 1 (coding exon 1) of the DNAJC21 gene. This alteration results from a G to T substitution at nucleotide position 32, causing the arginine (R) at amino acid position 11 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at